Publications dans lesquelles il/elle collabore avec GERARD PIÑOL RIPOLL (42)

2024

  1. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  2. Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 1, pp. 683-696

  3. Human lifespan and sex-specific patterns of resilience to disease: a retrospective population-wide cohort study

    BMC Medicine, Vol. 22, Núm. 1

2023

  1. Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 123

  2. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  3. Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738

  4. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

  5. Lithium management of periodic mood fluctuations in behavioural frontotemporal dementia: a case report

    Frontiers in Psychiatry, Vol. 14

  6. Spanish-Dementia Knowledge Assessment Scale (DKAS-S): Ecuadorian validation and comparison among Spanish health students

    BMC Geriatrics, Vol. 23, Núm. 1

2022

  1. Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  2. Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015

    BMC Public Health, Vol. 22, Núm. 1

2021

  1. Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease

    Sleep, Vol. 44, Núm. 2

  2. Effectiveness of technology-based interventions in detection, prevention, monitoring and treatment of patients at risk or diagnosed with mild cognitive impairment: Protocol for a systematic review

    BMJ Open, Vol. 11, Núm. 8

  3. Level of understanding of Alzheimer disease among caregivers and the general population

    Neurologia, Vol. 36, Núm. 6, pp. 426-432

  4. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

    Brain Communications, Vol. 3, Núm. 3

  5. Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s Disease

    Frontiers in Aging Neuroscience, Vol. 13

  6. Sleep profile predicts the cognitive decline of mild-moderate Alzheimer's disease patients

    Sleep, Vol. 44, Núm. 10

  7. The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients

    Alzheimer's Research and Therapy, Vol. 13, Núm. 1

2020

  1. Circulating MicroRNA Profile Associated with Obstructive Sleep Apnea in Alzheimer’s Disease

    Molecular Neurobiology, Vol. 57, Núm. 11, pp. 4363-4372

  2. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1